Does the gene matter? Genotype-phenotype and genotype-outcome associations in congenital melanocytic naevi.
The British Journal Of Dermatology
Polubothu, S S; McGuire, N N; Al-Olabi, L L; Baird, W W; Bulstrode, N N; Chalker, J J; Josifova, D D; Lomas, D D; O'Hara, J J; Ong, J J; Rampling, D D; Stadnik, P P; Thomas, A A; Wedgeworth, E E; Sebire, N J NJ; Kinsler, V A VA
Functional annotation of rare gene aberration drivers of pancreatic cancer.
Nature Communications
Tsang, Yiu Huen YH; Dogruluk, Turgut T; Tedeschi, Philip M PM; Wardwell-Ozgo, Joanna J; Lu, Hengyu H; Espitia, Maribel M; Nair, Nikitha N; Minelli, Rosalba R; Chong, Zechen Z; Chen, Fengju F; Chang, Qing Edward QE; Dennison, Jennifer B JB; Dogruluk, Armel A; Li, Min M; Ying, Haoqiang H; Bertino, Joseph R JR; Gingras, Marie-Claude MC; Ittmann, Michael M; Kerrigan, John J; Chen, Ken K; Creighton, Chad J CJ; Eterovic, Karina K; Mills, Gordon B GB; Scott, Kenneth L KL
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer.
Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology
Kopetz, Scott S; Desai, Jayesh J; Chan, Emily E; Hecht, Joel Randolph JR; O'Dwyer, Peter J PJ; Maru, Dipen D; Morris, Van V; Janku, Filip F; Dasari, Arvind A; Chung, Woonbook W; Issa, Jean-Pierre J JP; Gibbs, Peter P; James, Brian B; Powis, Garth G; Nolop, Keith B KB; Bhattacharya, Suman S; Saltz, Leonard L
Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma.
Clinical & Experimental Metastasis
Birkeland, Einar E; Busch, Christian C; Berge, Elisabet Ognedal EO; Geisler, Jürgen J; Jönsson, Göran G; Lillehaug, Johan Richard JR; Knappskog, Stian S; Lønning, Per Eystein PE
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.
Genes & Development
Vredeveld, Liesbeth C W LC; Possik, Patricia A PA; Smit, Marjon A MA; Meissl, Katrin K; Michaloglou, Chrysiis C; Horlings, Hugo M HM; Ajouaou, Abderrahim A; Kortman, Pim C PC; Dankort, David D; McMahon, Martin M; Mooi, Wolter J WJ; Peeper, Daniel S DS
Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Kirkwood, John M JM; Bastholt, Lars L; Robert, Caroline C; Sosman, Jeff J; Larkin, James J; Hersey, Peter P; Middleton, Mark M; Cantarini, Mireille M; Zazulina, Victoria V; Kemsley, Karin K; Dummer, Reinhard R
Clinical correlates of NRAS and BRAF mutations in primary human melanoma.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Ellerhorst, Julie A JA; Greene, Victoria R VR; Ekmekcioglu, Suhendan S; Warneke, Carla L CL; Johnson, Marcella M MM; Cooke, Carolyn P CP; Wang, Li-E LE; Prieto, Victor G VG; Gershenwald, Jeffrey E JE; Wei, Qingyi Q; Grimm, Elizabeth A EA